Neonatal methamphetamine-induced corticosterone release in rats is inhibited by adrenal autotransplantation without altering the effect of the drug on hippocampal serotonin

Neurotoxicology and Teratology

Volumn 32, Issue 3, 2010, Pages 356-361

  Grace, Curtis E ^a,b   Schaefer, Tori L ^a,b   Gudelsky, Gary A ^c   Williams, Michael T ^a,b   Vorhees, Charles V ^a,b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Adrenal autotransplantation.; Corticosterone; Methamphetamine; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CORTICOSTERONE; METHAMPHETAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOSTERONE RELEASE; DRUG ABUSE; FEMALE; HIPPOCAMPUS; MALE; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

ADRENAL GLANDS; ANIMALS; ANIMALS, NEWBORN; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTICOSTERONE; FEMALE; HIPPOCAMPUS; MALE; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TRANSPLANTATION, AUTOLOGOUS;

RATTUS;

EID: 77951209031     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2010.02.001     Document Type: Article

References (58)

1. Acevedo S.F., Pfankuch T., van M.P., Raber J. Role of histamine in short- and long-term effects of methamphetamine on the developing mouse brain. J. Neurochem. 2008, 107:976-986.
2. Aisa B., Tordera R., Lasheras B., Del R.J., Ramirez M.J. Cognitive impairment associated to HPA axis hyperactivity after maternal separation in rats. Psychoneuroendocrinology 2007, 32:256-266.
3. Belloni A.S., Vassanelli P., Robba C., Rebuffat P., Mazzocchi G., Nussdorfer G.G. Ultrastructural observations on the regeneration of adrenocortical autotransplants in the rat spleen. J. Anat. 1982, 135:245-253.
4. Burchfield D.J., Lucas V.W., Abrams R.M., Miller R.L., DeVane C.L. Disposition and pharmacodynamics of methamphetamine in pregnant sheep. JAMA 1991, 265:1968-1973.
5. Chang L., Cloak C., Jiang C.S., Farnham S., Tokeshi B., Buchthal S., Hedemark B., Smith L.M., Ernst T. Altered neurometabolites and motor integration in children exposed to methamphetamine in utero. Neuroimage 2009, 48:391-397.
6. Chang L., Smith L.M., LoPresti C., Yonekura M.L., Kuo J., Walot I., Ernst T. Smaller subcortical volumes and cognitive deficits in children with prenatal methamphetamine exposure. Psychiatry Res. 2004, 132:95-106.
7. Chomchai C., Na M.N., Watanarungsan P., Yossuck P., Chomchai S. Methamphetamine abuse during pregnancy and its health impact on neonates born at Siriraj Hospital, Bangkok, Thailand. Southeast Asian J. Trop. Med. Public Health 2004, 35:228-231.
8. Clancy B., Finlay B.L., Darlington R.B., Anand K.J. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007, 28:931-937.
9. Clancy B., Kersh B., Darlington R.B., Anand K.J., Finlay B.L. Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics 2006, 5:79-94.
10. Cloak C.C., Ernst T., Fujii L., Hedemark B., Chang L. Lower diffusion in white matter of children with prenatal methamphetamine exposure. Neurology 2009, 72:2068-2075.
11. Crawford C.A., Williams M.T., Newman E.R., McDougall S.A., Vorhees C.V. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content. Synapse 2003, 48:131-137.
12. Dixon S.D. Effects of transplacental exposure to cocaine and methamphetamine on the neonate. West. J. Med. 1989, 150:436-442.
13. Dixon S.D., Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J. Pediatr. 1989, 115:770-778.
14. Felszeghy K., Bagdy G., Nyakas C. Blunted pituitary-adrenocortical stress response in adult rats following neonatal dexamethasone treatment. J. Neuroendocrinol. 2000, 12:1014-1021.
15. Garcia-Bournissen F., Rokach B., Karaskov T., Koren G. Methamphetamine detection in maternal and neonatal hair: implications for fetal safety. Arch. Dis. Child., Fetal Neonatal Ed. 2007, 92:F351-F355.
16. Grace C.E., Schaefer T.L., Herring N.R., Skelton M.R., McCrea A.E., Vorhees C.V., Williams M.T. (+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats. Synapse 2008, 62:110-121.
17. Haughey H.M., Fleckenstein A.E., Hanson G.R. Differential regional effects of methamphetamine on the activities of tryptophan and tyrosine hydroxylase. J. Neurochem. 1999, 72:661-668.
18. Hodgson D.M., Knott B., Walker F.R. Neonatal endotoxin exposure influences HPA responsivity and impairs tumor immunity in Fischer 344 rats in adulthood. Pediatr. Res. 2001, 50:750-755.
19. Hotchkiss A.J., Gibb J.W. Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 1980, 214:257-262.
20. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Monitoring the Future national survey results on drug use, 1975-2007. Volume I: Secondary school students 2008, 1-738. National Institute on Drug Abuse, Bethesda, MD.
21. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Monitoring the Future national survey results on drug use, 1975-2007. Volume II: College students and adults ages 19-45 2008, 1-342. National Institute on Drug Abuse, Bethesda, MD.
22. Kalinichev M., Easterling K.W., Plotsky P.M., Holtzman S.G. Long-lasting changes in stress-induced corticosterone response and anxiety-like behaviors as a consequence of neonatal maternal separation in Long-Evans rats. Pharmacol. Biochem. Behav. 2002, 73:131-140.
23. Kamphuis P.J., Bakker J.M., Broekhoven M.H., Kunne C., Croiset G., Lentjes E.G., Tilders F.J., van B.F., Wiegant V.M. Enhanced glucocorticoid feedback inhibition of hypothalamo-pituitary-adrenal responses to stress in adult rats neonatally treated with dexamethasone. Neuroendocrinology 2002, 76:158-169.
24. Kokoshka J.M., Fleckenstein A.E., Wilkins D.G., Hanson G.R. Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine. J. Neurochem. 2000, 75:2095-2102.
25. Kuhn D.M. Tryptophan hydroxylase regulation. Drug-induced modifications that alter serotonin neuronal function. Adv. Exp. Med. Biol. 1999, 467:19-27.
26. Little B.B., Snell L.M., Gilstrap L.C. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet. Gynecol. 1988, 72:541-544.
27. Mazer C., Muneyyirci J., Taheny K., Raio N., Borella A., Whitaker-Azmitia P. Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res. 1997, 760:68-73.
28. Melega W.P., Cho A.K., Harvey D., Lacan G. Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. Synapse 2007, 61:216-220.
29. Mordenti J., Chapell W. The use of interspecies scaling in toxicokinetics. Toxicokinetics in New Drug Development 1989, 42-96. Pergamon Press, New York.
30. Nabishah B.M., Khalid B.A., Morat P.B., Zanariyah A. Regeneration of adrenal cortical tissue after adrenal autotransplantation. Exp. Clin. Endocrinol. Diabetes 1998, 106:419-424.
31. Okamoto T., Fujimoto Y., Obara T., Ito Y., Kodama T. Experimental study on adrenal autografts in rats to preserve normal adrenocortical function after bilateral adrenalectomy. Eur. Surg. Res. 1992, 24:112-118.
32. Oro A.S., Dixon S.D. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J. Pediatr. 1987, 111:571-578.
33. Sapolsky R.M., Meaney M.J. Maturation of the adrenocortical stress response: neuroendocrine control mechanisms and the stress hyporesponsive period. Brain Res. 1986, 396:64-76.
34. Schaefer T.L., Ehrman L.A., Gudelsky G.A., Vorhees C.V., Williams M.T. Comparison of monoamine and corticosterone levels 24h following (+)methamphetamine, (+/-)3, 4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat. J. Neurochem. 2006, 98:1369-1378.
35. Schaefer T.L., Skelton M.R., Herring N.R., Gudelsky G.A., Vorhees C.V., Williams M.T. Short- and long-term effects of (+)-methamphetamine and (+/-)-3, 4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment. J. Neurochem. 2008, 104:1674-1685.
36. Skelton M.R., Williams M.T., Schaefer T.L., Vorhees C.V. Neonatal (+)-methamphetamine increases brain derived neurotrophic factor, but not nerve growth factor, during treatment and results in long-term spatial learning deficits. Psychoneuroendocrinology 2007, 32:734-745.
37. Smith L., Yonekura M.L., Wallace T., Berman N., Kuo J., Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J. Dev. Behav. Pediatr. 2003, 24:17-23.
38. Smith L.M., LaGasse L.L., Derauf C., Grant P., Shah R., Arria A., Huestis M., Haning W., Strauss A., Grotta S.D., Fallone M., Liu J., Lester B.M. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol. Teratol. 2008, 30:20-28.
39. Srougi M., Gittes R.F. Adrenal autotransplantation. Urol. Surv. 1978, 28:41-48.
40. Srougi M., Gittes R.F., Underwood R. Influence of exogenous glucocorticoids and adrenocorticotropic hormone on experimental adrenal autografts. Surg. Forum 1978, 29:109-111.
41. Struthers J.M., Hansen R.L. Visual recognition memory in drug-exposed infants. J. Dev. Behav. Pediatr. 1992, 13:108-111.
42. Terplan M., Smith E.J., Kozloski M.J., Pollack H.A. Methamphetamine use among pregnant women. Obstet. Gynecol. 2009, 113:1285-1291.
43. Ulrich-Lai Y.M., Engeland W.C. Rat adrenal transplants are reinnervated: an invalid model of denervated adrenal cortical tissue. J. Neuroendocrinol. 2000, 12:881-893.
44. Vendeira P., Magalhaes M.M., Magalhaes M.C. Autotransplantation of the adrenal cortex: a morphological and autoradiographic study. Anat. Rec. 1992, 232:262-272.
45. Vorhees C.V., Ahrens K.G., Acuff-Smith K.D., Schilling M.A., Fisher J.E. Methamphetamine exposure during early postnatal development in rats: I. Acoustic startle augmentation and spatial learning deficits. Psychopharmacology (Berl) 1994, 114:392-401.
46. Vorhees C.V., Herring N.R., Schaefer T.L., Grace C.E., Skelton M.R., Johnson H.L., Williams M.T. Effects of neonatal (+)-methamphetamine on path integration and spatial learning in rats: effects of dose and rearing conditions. Int. J. Dev. Neurosci. 2008, 26:599-610.
47. Vorhees C.V., Inman-Wood S.L., Morford L.L., Broening H.W., Fukumura M., Moran M.S. Adult learning deficits after neonatal exposure to D-methamphetamine: selective effects on spatial navigation and memory. J. Neurosci. 2000, 20:4732-4739.
48. Vorhees C.V., Reed T.M., Schilling M.S., Acuff-Smith K.D., Fisher J.E., Moran M.S. Neonatal methamphetamine-induced long-term acoustic startle facilitation in rats as a function of prepulse stimulus intensity. Neurotoxicol. Teratol. 1996, 18:135-139.
49. Vorhees C.V., Skelton M.R., Williams M.T. Age-dependent effects of neonatal methamphetamine exposure on spatial learning. Behav. Pharmacol. 2007, 18:549-562.
50. Walker C.D., Akana S.F., Cascio C.S., Dallman M.F. Adrenalectomy in the neonate: adult-like adrenocortical system responses to both removal and replacement of corticosterone. Endocrinology 1990, 127:832-842.
51. Walker C.D., Sapolsky R.M., Meaney M.J., Vale W.W., Rivier C.L. Increased pituitary sensitivity to glucocorticoid feedback during the stress nonresponsive period in the neonatal rat. Endocrinology 1986, 119:1816-1821.
52. Williams M.T., Blankenmeyer T.L., Schaefer T.L., Brown C.A., Gudelsky G.A., Vorhees C.V. Long-term effects of neonatal methamphetamine exposure in rats on spatial learning in the Barnes maze and on cliff avoidance, corticosterone release, and neurotoxicity in adulthood. Brain Res. Dev. Brain Res. 2003, 147:163-175.
53. Williams M.T., Brown R.W., Vorhees C.V. Neonatal methamphetamine administration induces region-specific long-term neuronal morphological changes in the rat hippocampus, nucleus accumbens and parietal cortex. Eur. J. Neurosci. 2004, 19:3165-3170.
54. Williams M.T., Inman-Wood S.L., Morford L.L., McCrea A.E., Ruttle A.M., Moran M.S., Rock S.L., Vorhees C.V. Preweaning treatment with methamphetamine induces increases in both corticosterone and ACTH in rats. Neurotoxicol. Teratol. 2000, 22:751-759.
55. Williams M.T., Moran M.S., Vorhees C.V. Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze. Psychopharmacology (Berl) 2003, 168:329-338.
56. Williams M.T., Morford L.L., Wood S.L., Wallace T.L., Fukumura M., Broening H.W., Vorhees C.V. Developmental D-methamphetamine treatment selectively induces spatial navigation impairments in reference memory in the Morris water maze while sparing working memory. Synapse 2003, 48:138-148.
57. Williams M.T., Schaefer T.L., Furay A.R., Ehrman L.A., Vorhees C.V. Ontogeny of the adrenal response to (+)-methamphetamine in neonatal rats: The effect of prior drug exposure. Stress 2006, 9:153-163.
58. Williams M.T., Vorhees C.V., Boon F., Saber A.J., Cain D.P. Methamphetamine exposure from postnatal day 11 to 20 causes impairments in both behavioral strategies and spatial learning in adult rats. Brain Res. 2002, 958:312-321.